Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

177Lu-CTR-FAPI for the Treatment of Thyroid Cancer: A Prospective, Multi-center, Open-labeled, Single-arm, Phase I Study

NCT07438847 is registered in ClinicalTrials.gov with SHAOYAN LIU as lead sponsor.

NCT NCT07438847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07438847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer: A Prospective, Multi-center, Open-labeled, Single-arm, Phase I Study
Lead sponsor
SHAOYAN LIU
Phase
Phase 1
Overall status
Recruiting
Start date
January 1, 2026
Completion date
December 31, 2027
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer